Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CUE-101 Before Surgery or Chemoradiation in HPV16+ Oropharyngeal Cancer
NCT04852328Phase 2Recruiting
- Sponsor
- Washington University School of Medicine
- Start
- Dec 2021
- Primary completion
- Oct 2027
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of CUE-101 in oropharyngeal squamous cell carcinoma (OPSCC), sponsored by Washington University School of Medicine. Started Dec 2021; status: recruiting.
02
Drugs
CUE-101
03
Conditions
oropharyngeal squamous cell carcinoma (OPSCC)
Beyond the preview
Go deeper on NCT04852328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04852328.